Is the Mayne Pharma Group Ltd share price heading lower?

The Mayne Pharma Group Ltd (ASX:MYX) share price has lost almost two-thirds of its value in the last 12 months. Can it fall further?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Tuesday the Mayne Pharma Group Ltd (ASX: MYX) share price finished the day just 1.5 cents higher than its multi-year low of 60 cents.

This means the pharmaceutical company's shares have now lost almost two-thirds of their value since this time last year.

Are they in the bargain bin now?

That's the million dollar question. If pricing pressures ease in the U.S. generic drugs market then there's every chance that Mayne Pharma will prove to be an absolute steal at the current share price.

But as I explained at the start of the month, the generic drugs market is showing no signs of a recovery in prices just yet.

Global generic drugs giant Teva Pharmaceutical saw its shares shed 20% of their value on November 2 after its Generic Drugs segment posted a 37% decline in quarterly profit to US$619 million.

Furthermore, Teva revised its full-year guidance lower and failed to provide any upbeat commentary on the industry. In light of this, I feel it could be some time before generic drug prices recover, which could mean the Mayne Pharma share price decline hasn't ended yet.

What now?

Instead of risking your hard-earned money in Mayne Pharma I would suggest you consider fellow healthcare share CSL Limited (ASX: CSL). I think it is capable of growing its bottom line at a solid rate for the foreseeable future thanks to its immunoglobulins, specialty products, and vaccines businesses.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »